-
1
-
-
84875388096
-
-
European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus. Last accessed 31 January 2013
-
European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus. http://www.ema.europa.eu/docs/en-GB/ document-library/Scientific-guideline/2012/ 06/WC500129256.pdf. Last accessed 31 January 2013.
-
-
-
-
2
-
-
84875390831
-
-
The Shorter Oxford English Dictionary, University Press
-
The Shorter Oxford English Dictionary, 1983. Guild Publishing for Oxford University Press.
-
(1983)
Guild Publishing for Oxford
-
-
-
3
-
-
0030054184
-
Investigation of hypoglycaemia
-
Marks V, Teale JD. Investigation of hypoglycaemia. Clin Endocrinol 1996;44:133-6. (Pubitemid 26042965)
-
(1996)
Clinical Endocrinology
, vol.44
, Issue.2
, pp. 133-136
-
-
Marks, V.1
Teale, J.D.2
-
4
-
-
0024562512
-
Hypoglycemia. Definition, clinical presentations, classification, and laboratory tests
-
Field JB. Hypoglycemia. Definition, clinical presentations, classification, and laboratory tests. Endocrinol Metab Clin North Am 1989;18:27-43. (Pubitemid 19058100)
-
(1989)
Endocrinology and Metabolism Clinics of North America
, vol.18
, Issue.1
, pp. 27-43
-
-
Field, J.B.1
-
5
-
-
18144388647
-
Defining and reporting hypoglycemia in diabetes
-
American Diabetes Association Workgroup on Hypoglycemia.
-
American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes. Diabetes Care 2005;28:1245-9.
-
(2005)
Diabetes Care
, vol.28
, pp. 1245-1249
-
-
-
6
-
-
0028811401
-
Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated iddm
-
Maran A, Lomas J, Macdonald IA, et al. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia 1995;38:1412-8.
-
(1995)
Diabetologia
, vol.38
, pp. 1412-1418
-
-
Maran, A.1
Lomas, J.2
Macdonald, I.A.3
-
7
-
-
0028082320
-
Protection by lactate of cerebral function during hypoglycaemia
-
DOI 10.1016/S0140-6736(94)90876-1
-
Maran A, Cranston I, Lomas J, et al. Protection by lactate of cerebral function during hypoglycaemia. Lancet 1994;343:16-20. (Pubitemid 24017609)
-
(1994)
Lancet
, vol.343
, Issue.8888
, pp. 16-20
-
-
Maran, A.1
Cranston, I.2
Lomas, J.3
MacDonald, I.4
Amiel, S.A.5
-
8
-
-
0026035949
-
Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans
-
Heller S.R., Cryer P.E. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 1991;40:223-6.
-
(1991)
Diabetes
, vol.40
, pp. 223-226
-
-
Heller, S.R.1
Cryer, P.E.2
-
9
-
-
0028237872
-
Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes
-
DOI 10.1016/S0140-6736(94)91336-6
-
Cranston I, Lomas J, Maran A, et al. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994;344:283-7. (Pubitemid 24230294)
-
(1994)
Lancet
, vol.344
, Issue.8918
, pp. 283-287
-
-
Cranston, I.1
Lomas, J.2
Maran, A.3
Macdonald, I.4
Amiel, S.A.5
-
10
-
-
0001720558
-
The surgical therapy of hyperinsulinism
-
Whipple AO. The surgical therapy of hyperinsulinism. J Internat Chir 1938;3:237-76.
-
(1938)
J Internat Chir
, vol.3
, pp. 237-276
-
-
Whipple, A.O.1
-
11
-
-
0030837024
-
Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans
-
Davis SN, Shavers X, Mosqueda-Garcia R, et al. Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 1997;46:1328-35. (Pubitemid 27315282)
-
(1997)
Diabetes
, vol.46
, Issue.8
, pp. 1328-1335
-
-
Davis, S.N.1
Shavers, C.2
Mosqueda-Garcia, R.3
Costa, F.4
-
12
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
DOI 10.1056/NEJMoa0802743
-
Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59. (Pubitemid 351831356)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.24
, pp. 2545-2559
-
-
Friedewald, W.T.1
Buse, J.B.2
Bigger, J.T.3
Byington, R.P.4
Cushman, W.C.5
Gerstein, H.C.6
Ginsberg, H.N.7
Goff Jr., D.C.8
Grimm Jr., R.H.9
Ismail-Beigi, F.10
Probstfield, J.L.11
Simons-Morton, D.G.12
-
15
-
-
84875402650
-
-
US Food and Drug Administration. Last accessed 12 February 2013
-
US Food and Drug Administration. Common problems with the use of glucose meters at the point of care. http://www.fda.gov/MedicalDevices/Safety/ AlertsandNotices/ TipsandArticlesonDeviceSafety/ucm109449.htm. Last accessed 12 February 2013.
-
Common problems with the use of glucose meters at the point of care.
-
-
|